Conflux provides a physician‑centered AI platform that integrates with laboratory information systems to deliver real‑time, context‑aware assistance while pathologists author reports. It surfaces relevant clinical evidence, performs pre‑sign‑out checks for missing biomarkers and inconsistent measurements, and offers on‑demand review of completed reports, all within the existing reporting workflow.
Funding
Funding not disclosed
Founders
Product
Problem
Pathologists face increasing case volumes, expanding test panels, and constantly evolving guidelines, leading to fragmented evidence, missed biomarkers, and inconsistent measurements that can delay treatment and affect reimbursement.
Solution
Conflux offers a physician‑centered AI platform that integrates directly with laboratory information systems (LIS) to provide real‑time, context‑aware assistance during report authoring. As the pathologist writes, the system captures case data, surfaces relevant clinical and guideline evidence, and performs pre‑sign‑out checks to flag missing biomarkers, inconsistent measurements, or documentation gaps. The platform also supports on‑demand review of completed reports, delivering structured context and evidence searches without leaving the existing workflow. By embedding within the reporting environment, Conflux aims to improve diagnostic completeness, reduce errors, and streamline compliance with standards such as CAP protocols.
Target Audience
Primary customers are pathology departments in hospitals and clinical laboratories that use LIS platforms for histology and molecular reporting.
Features
- Ambient Sync captures case information from the LIS in real time and delivers live evidence, error checks, and ancillary recommendations as the report is written
- Instant Review allows users to paste a finished report and receive automated evidence search, structured context, and pre‑sign‑out validation on demand
- Context‑aware diagnostic intelligence that highlights missing biomarkers, inconsistent measurements, and undocumented elements to prevent treatment delays and reimbursement issues
- Seamless integration with both glass and digital pathology labs, working within the pathologist’s existing reporting workflow without requiring separate interfaces
- Enterprise deployment option that embeds the AI directly into the LIS for institution‑wide adoption and standardized reporting practices